| 
            タナベ ケンジ
            TANABE Kenji
           田邊 賢司 所属 研究施設 研究施設 職種 准教授  | 
      |
| 論文種別 | 原著 | 
| 言語種別 | 英語 | 
| 査読の有無 | 査読なし | 
| 表題 | Image-based phenotypic profiling of a chemogenomic screening library identifies novel druggable targets in the EGFR pathway | 
| 掲載誌名 | 正式名:BioRxiv | 
| 掲載区分 | 国外 | 
| 巻・号・頁 | pp.440090 | 
| 著者・共著者 | Kenji Tanabe | 
| 担当区分 | 筆頭著者,責任著者 | 
| 発行年月 | 2021/04/17 | 
| 概要 | The gene encoding epidermal growth factor receptor (EGFR) is a major driver gene in cancer. Many drugs targeting EGFR-associated molecules have been developed, yet many have failed in clinical trials due to a lack of efficacy and/or unexpected side effects. In this study, I used image-based phenotypic profiling to screen a pharmacologically active compound library with the aim of identifying new druggable targets in the EGFR pathway. As anticipated, the phenotypic screen identified compounds that produce phenotypes resulting from targeting a known specific molecule or pathway. The assay also showed that compounds with diverse known mechanisms of action produced similar, EGFR-related cellular phenotypes. Biochemical assays revealed that those compounds share a previously unappreciated common target/pathway, showing that the image-based assay can identify new target molecules that are independent of the compound's known target. Further experiments showed that ROCK1 and PSMD2 are novel druggable targets within the EGFR pathway. | 
| DOI | https://doi.org/10.1101/2021.04.16.440090 |